S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
OTCMKTS:RDSMY

Koninklijke DSM (RDSMY) Stock Price, News & Analysis

$33.85
+1.08 (+3.30%)
(As of 11/11/2022)
Today's Range
$33.11
$33.90
50-Day Range
$33.85
$33.85
52-Week Range
$26.59
$56.92
Volume
56,500 shs
Average Volume
116,034 shs
Market Capitalization
$23.67 billion
P/E Ratio
N/A
Dividend Yield
1.09%
Price Target
N/A
RDSMY stock logo

About Koninklijke DSM Stock (OTCMKTS:RDSMY)

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

RDSMY Stock Price History

RDSMY Stock News Headlines

Downing Strate. Share Chat
Koninklijke DSM N.V. (DSM.DE)
Elon Musk’s ChatGPT Could Soon Mint New Millionaires
Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.
Koninklijke DSM NV DSM
DSM2.BE - Koninklijke DSM NV
UBS maintains Koninklijke DSM at Buy
Koninklijke DSM N.V. (DSM.AS)
Elon Musk’s ChatGPT Could Soon Mint New Millionaires
Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.
Koninklijke DSM N.V.
Royal DSM: DSM - delivery of shares
DSM - delivery of shares
Koninklijke DSM NV (0NPP)
DSM provides nine months 2022 trading update
15 Most Valuable Dutch Companies in the World
Koninklijke DSM Earnings, Revenue Miss in Q2
DSM reports H1 2022 results
See More Headlines
Receive RDSMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2020
Today
4/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Current Symbol
OTCMKTS:RDSMY
Previous Symbol
NASDAQ:RDSMY
Employees
21,358
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.89 billion
Cash Flow
$2.29 per share
Book Value
$11.78 per share

Miscellaneous

Free Float
N/A
Market Cap
$23.67 billion
Optionable
Not Optionable
Beta
1.00
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Dimitri de Vreeze (Age 55)
    Co-CEO, COO & Member of the Managing Board
    Comp: $2.03M
  • Ms. Geraldine Matchett (Age 50)
    Co-CEO, CFO, Member of the Managing Board & Acting EVP of People & Organization
    Comp: $1.98M
  • Mr. Dave Huizing
    VP of Investor Relations
  • Ms. Lieke de Jong-Tops
    Sr. Communications Mang.
  • Mr. Rob J. Atsma (Age 76)
    Head of Energie Beheer Nederland
  • Mr. Paul Gilgen (Age 77)
    Head of Manufacturing & Purchasing of DSM Nutritional Products
  • Mr. Manfred Eggersdorfer (Age 71)
    Sr. VP of Nutrition Science & Advocacy
  • Mr. Bruno Müller (Age 66)
    Head of Strategy & VITAL Project - Nutritional Products
  • Mr. Jan Wolters (Age 79)
    Head of Fine Chemicals
  • Mr. Luca Rosetto (Age 59)
    Sr. VP of Operations - Nutritional Products

Should I Buy Koninklijke DSM Stock? RDSMY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Koninklijke DSM:

  • Koninklijke DSM operates in the nutrition, health, and sustainable living sectors, which are growing industries with increasing demand for innovative products and solutions.
  • The company's diversified business segments, including Nutrition, Materials, and Innovation Center, provide a wide range of products and services, reducing dependency on a single market.
  • Recent merger with a Swiss company opens up new opportunities for expansion and market reach, potentially leading to increased revenue and profitability.
  • Strong focus on research and development, leading to the introduction of cutting-edge products such as specialty plastics for various industries and biomedical materials for medical applications.
  • Current stock price of Koninklijke DSM is showing positive momentum, indicating investor confidence and potential for capital appreciation.

Cons

Investors should be bearish about investing in Koninklijke DSM for these reasons:

  • Fluctuations in raw material prices, especially in the chemicals industry, can impact the company's profitability and margins.
  • Intense competition in the markets Koninklijke DSM operates in may lead to pricing pressures and reduced market share.
  • Economic uncertainties and global events can affect consumer spending patterns, potentially impacting the demand for the company's products.
  • Regulatory changes and environmental concerns could result in increased compliance costs and restrictions on certain product lines, affecting overall operations.
  • Market volatility and macroeconomic factors can influence the stock price of Koninklijke DSM, leading to potential investment risks.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Koninklijke DSM pros and cons to contact@marketbeat.com.

RDSMY Stock Analysis - Frequently Asked Questions

How have RDSMY shares performed in 2024?

Koninklijke DSM's stock was trading at $33.85 at the beginning of 2024. Since then, RDSMY stock has increased by 0.0% and is now trading at $33.85.
View the best growth stocks for 2024 here
.

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) released its earnings results on Tuesday, November, 3rd. The basic materials company reported $0.30 earnings per share for the quarter, missing analysts' consensus estimates of $0.31 by $0.01. The basic materials company had revenue of $2.29 billion for the quarter.
Read the conference call transcript
.

Is Koninklijke DSM a good dividend stock?

Koninklijke DSM (OTCMKTS:RDSMY) pays an annual dividend of $0.37 per share and currently has a dividend yield of 1.09%.
Read our dividend analysis for RDSMY.

How do I buy shares of Koninklijke DSM?

Shares of RDSMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RDSMY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners